APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,619 | +30.2% | 138,513 | -26.1% | 0.02% | +38.5% |
| Q4 2022 | $9,691 | -100.0% | 187,413 | -45.7% | 0.01% | -60.6% |
| Q3 2022 | $23,571,000 | +1745.8% | 345,113 | +1607.6% | 0.03% | +1550.0% |
| Q2 2021 | $1,277,000 | -92.0% | 20,211 | -94.6% | 0.00% | -90.0% |
| Q1 2021 | $16,027,000 | +29.5% | 373,513 | +72.7% | 0.02% | +53.8% |
| Q4 2020 | $12,373,000 | +1972.5% | 216,313 | +1008.6% | 0.01% | – |
| Q4 2019 | $597,000 | +16.8% | 19,513 | -25.5% | 0.00% | – |
| Q1 2019 | $511,000 | – | 26,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |